iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
P/B ratio for iSpecimen Inc. (ISPC)
P/B ratio as of 2023: 9.29
According to iSpecimen Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 9.29. At the end of 2022 the company had a P/B ratio of 0.60.
P/B ratio history for iSpecimen Inc. from 2018 to 2023
P/B ratio at the end of each year
| Year | P/B ratio |
|---|---|
| 2023 | 9.29 |
| 2022 | 0.60 |
| 2021 | 2.14 |
| 2020 | -0.25 |
| 2019 | -0.29 |
| 2018 | -0.36 |